RICHMOND, Va. / Dec 07, 2023 / Business Wire / Owens & Minor, Inc. (NYSE: OMI) has unveiled its new purpose, Life Takes Care. More than a motto or tagline, Life Takes Care captures the company’s unique approach to caring for both the business and the humanity at the heart of healthcare.
“Owens & Minor has always been driven by a strong sense of the importance of the work we do behind the scenes for the patients, providers and communities we serve,” said Edward A. Pesicka, President & Chief Executive Officer, Owens & Minor. “Defining that sense of purpose in the statement Life Takes Care allows us to better harness the unstoppable collective strength, creativity and compassion of our teammates as we continue to move our business forward.”
The past few years have brought about historic shifts affecting not only Owens & Minor, but also the healthcare industry as a whole, accelerating trends in where, when and how care is delivered. Research shows that purpose-driven companies experience approximately 14% greater revenue growth, are nearly two times as likely to have above average returns, and have +8% reduced turnover; have +12% fewer safety incidents; and +4% increased profitability. Additionally, a study of high-growth companies found company purpose to be one of four key growth drivers.
Life Takes Care was uncovered and developed using teammate perspectives as well as strategic insights from company leadership. This statement of purpose encompasses the entirety of Owens & Minor’s global business: the Products & Healthcare Services and Patient Direct business segments as well as its affiliated brands, Apria®, Byram® and HALYARD*. Life Takes Care was first unveiled on December 6, 2023 and will be celebrated throughout its inaugural year in 2024.
To learn more about Life Takes Care and Owens & Minor’s vital role in healthcare, visit www.owens-minor.com/about.
About Owens & Minor
Owens & Minor, Inc. (NYSE: OMI) is a Fortune 500 global healthcare solutions company providing essential products and services that support care from the hospital to the home.
For over 100 years, Owens & Minor and its affiliated brands, Apria®, Byram® and HALYARD*, have helped to make each day better for the patients, providers, and communities we serve.
Powered by more than 20,000 teammates worldwide, Owens & Minor delivers comfort and confidence behind the scenes so healthcare stays at the forefront. Owens & Minor exists because every day, everywhere, Life Takes Care™.
For more information about Owens & Minor and our affiliated brands, visit owens-minor.com or follow us on LinkedIn and Instagram.
*Registered Trademark or Trademark of O&M Halyard or its affiliates.
Last Trade: | US$14.83 |
Daily Change: | -0.02 -0.13 |
Daily Volume: | 437,069 |
Market Cap: | US$1.140B |
December 02, 2024 November 04, 2024 September 10, 2024 September 09, 2024 August 02, 2024 |
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREC4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MOREEnd of content
No more pages to load